GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Item 9 Labs Corp (OTCPK:INLB) » Definitions » Cyclically Adjusted PB Ratio

Item 9 Labs (Item 9 Labs) Cyclically Adjusted PB Ratio : (As of Apr. 30, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Item 9 Labs Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Item 9 Labs Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Item 9 Labs's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Item 9 Labs Cyclically Adjusted PB Ratio Chart

Item 9 Labs Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Item 9 Labs Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Item 9 Labs's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Item 9 Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Item 9 Labs's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Item 9 Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Item 9 Labs's Cyclically Adjusted PB Ratio falls into.



Item 9 Labs Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Item 9 Labs's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2023 is calculated as:

For example, Item 9 Labs's adjusted Book Value per Share data for the three months ended in Jun. 2023 was:

Adj_Book=Book Value per Share/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=0.514/128.7287*128.7287
=0.514

Current CPI (Jun. 2023) = 128.7287.

Item 9 Labs Quarterly Data

Book Value per Share CPI Adj_Book
201309 -1.541 98.790 -2.008
201312 -2.297 98.326 -3.007
201403 -0.693 99.695 -0.895
201406 -0.771 100.560 -0.987
201409 -0.847 100.428 -1.086
201412 -0.915 99.070 -1.189
201503 -1.077 99.621 -1.392
201506 -1.237 100.684 -1.582
201509 -1.381 100.392 -1.771
201512 -1.355 99.792 -1.748
201603 -1.311 100.470 -1.680
201606 -1.355 101.688 -1.715
201609 -0.280 101.861 -0.354
201612 -0.292 101.863 -0.369
201703 -0.293 102.862 -0.367
201706 -0.290 103.349 -0.361
201709 0.129 104.136 0.159
201712 -0.245 104.011 -0.303
201803 0.052 105.290 0.064
201806 0.000 106.317 0.000
201809 0.048 106.507 0.058
201812 0.000 105.998 0.000
201903 0.000 107.251 0.000
201906 0.222 108.070 0.264
201909 0.117 108.329 0.139
201912 0.093 108.420 0.110
202003 0.181 108.902 0.214
202006 0.178 108.767 0.211
202009 0.143 109.815 0.168
202012 0.210 109.897 0.246
202103 1.505 111.754 1.734
202106 1.471 114.631 1.652
202109 0.908 115.734 1.010
202112 0.890 117.630 0.974
202203 0.862 121.301 0.915
202206 0.815 125.017 0.839
202209 0.635 125.227 0.653
202212 0.604 125.222 0.621
202303 0.567 127.348 0.573
202306 0.514 128.729 0.514

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Item 9 Labs  (OTCPK:INLB) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Item 9 Labs Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Item 9 Labs's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Item 9 Labs (Item 9 Labs) Business Description

Traded in Other Exchanges
N/A
Address
2111 E. Highland Avenue, Suite B375, Phoenix, AZ, USA, 85016
Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. It also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.
Executives
Taylor Lawrence X. Iii director 2727 N 3RD STREET, SUITE 201, PHOENIX AZ 85004
Eric Kutscher director 2727 N 3RD STREET, SUITE 201, PHOENIX AZ 85004
Michael P Keskey director C/O ITEM 9 LABS, 2727 N. 3RD STREET, SUITE 201, PHOENIX AZ 85004
Douglas P Bowden director C/O ITEM 9 LABS 2727 N. 3RD STREET., SUITE 201, PHOENIX AZ 85004
Christopher Leland Wolven officer: Chief Operating Officer 5743 N 19TH ST, PHOENIX AZ 85016
Sara Gullickson director, officer: Chief Executive Officer 1709 BETHANY RD, PHOENIX AZ 85016
Andrew Douglas Bowden director 3621 N 39TH ST, PHOENIX AZ 85018
Robert E Mikkelsen officer: CFO, Secretary, Treasurer 2033 N OVERFIELD RD, CASA GRANDE AZ 85194
Patrick Sean Dugan 10 percent owner 2033 N OVERFIELD RD, CASA GRANDE AZ 85194
Andrew Poirier 10 percent owner 1946 E RANCHO DR, PHOENIX AZ 85016
Bryce Skalla director, officer: President 2033 N OVERFIELD RD, CASA GRANDE AZ 85194
Cohen Daniel E Md director, officer: President 10035 GRISTMILL RIDGE, EDEN PRAIRIE MN 55347
Hayjour Family Limited Partnership director, officer: President & CEO 10799 N 90TH STREET, SUITE 200, SCOTTSDALE AZ 85260
Jessica L Smith officer: CFO, Secretary, Treasurer 8399 E. INDIAN SCHOOL RD., SUITE 202, SCOTTSDALE AZ 85251
Lorrie Henderson officer: Chief Operating Officer 8399 E INDIAN SCHOOL RD, SUITE 202, SCOTTSDALE AZ 85251